AAAAAA
Results: 26-50/108
Authors:
KRAMERGUTH A
QUASCHNING T
PAVENSTADT H
GALLE J
NAUCK M
BAUMSTARK MW
SCHOLLMEYER P
MARZ W
WANNER C
Citation: A. Kramerguth et al., UPTAKE AND METABOLISM OF LIPOPROTEINS FROM PATIENTS WITH DIABETES-MELLITUS TYPE-II BY GLOMERULAR EPITHELIAL-CELLS, Nephrology, dialysis, transplantation, 12(7), 1997, pp. 1336-1343
Authors:
GALLE J
WANNER C
Citation: J. Galle et C. Wanner, OXIDATIVE STRESS AND VASCULAR INJURY - RELEVANT FOR ATHEROGENESIS IN UREMIC PATIENTS, Nephrology, dialysis, transplantation, 12(12), 1997, pp. 2480-2483
Authors:
QUASCHNING T
KONIGER M
KRAMERGUTH A
GREIBER S
PAVENSTADT H
NAUCK M
SCHOLLMEYER P
WANNER C
Citation: T. Quaschning et al., RECEPTOR-MEDIATED LIPOPROTEIN UPTAKE BY HUMAN GLOMERULAR CELLS - COMPARISON WITH SKIN FIBROBLASTS AND HEPG2 CELLS, Nephrology, dialysis, transplantation, 12(12), 1997, pp. 2528-2536
Authors:
ZIMMERMANN J
SCHRAMM L
MULZER E
HEIDBREDER E
HENRICH HA
WANNER C
Citation: J. Zimmermann et al., CARDIOVASCULAR RISK-FACTORS IN DIABETIC N EPHROPATHY, Medizinische Klinik, 92(2), 1997, pp. 74-78
Authors:
GREIBER S
WANNER C
Citation: S. Greiber et C. Wanner, LIPOPROTEIN(A) IN NEPHROTIC SYNDROME AND END-STAGE RENAL-DISEASE, Mineral and electrolyte metabolism, 23(3-6), 1997, pp. 161-165
Authors:
KRAMERGUTH A
BUSCH GL
KABA NK
SCHWEDLER S
WANNER C
LANG F
Citation: A. Kramerguth et al., EFFECT OF OSMOLARITY ON LDL BINDING AND INTERNALIZATION IN HEPATOCYTES, American journal of physiology. Cell physiology, 42(4), 1997, pp. 1409-1415
Authors:
WANNER C
ZIMMERMANN J
SCHRAMM L
Citation: C. Wanner et al., DYSLIPIDEMIA IN CAPD PATIENTS - INCIDENCE , QUALITY, ATHEROGENICITY AND POSSIBLE CONSEQUENCES, Nieren- und Hochdruckkrankheiten, 26, 1997, pp. 46-48
Authors:
WANNER C
GREIBER S
KRAMERGUTH A
HEINLOTH A
GALLE J
Citation: C. Wanner et al., LIPIDS AND PROGRESSION OF RENAL-DISEASE - ROLE OF MODIFIED LOW-DENSITY-LIPOPROTEIN AND LIPOPROTEIN(A), Kidney international, 1997, pp. 102-106
Authors:
WANNER C
ZIMMERMANN J
QUASCHNING T
GALLE J
Citation: C. Wanner et al., INFLAMMATION, DYSLIPIDEMIA AND VASCULAR RISK-FACTORS IN HEMODIALYSIS-PATIENTS, Kidney international, 52, 1997, pp. 53-55
Authors:
GALLE J
HEINLOTH A
SCHWEDLER S
WANNER C
Citation: J. Galle et al., EFFECT OF HDL AND ATHEROGENIC LIPOPROTEINS ON FORMATION OF O-2(-) ANDRENIN RELEASE IN JUXTAGLOMERULAR CELLS, Kidney international, 51(1), 1997, pp. 253-260
Authors:
BARTENS W
KRAMERGUTH A
WANNER C
Citation: W. Bartens et al., CORTICOTROPIN INCREASES THE RECEPTOR-SPECIFIC UPTAKE OF NATIVE LOW-DENSITY-LIPOPROTEIN (LDL) - BUT NOT OF OXIDIZED LDL AND NATIVE OR OXIDIZED LIPOPROTEIN(A) [LP(A)] - IN HEPG2 CELLS - NO EVIDENCE FOR LP(A) CATABOLISM VIA THE LDL-RECEPTOR, Metabolism, clinical and experimental, 46(7), 1997, pp. 726-729
Authors:
SPEISER P
WANNER C
TEMPFER C
MITTELBOCK M
HANZAL E
BANCHERTODESCA D
GITSCH G
REINTHALLER A
KAINZ C
Citation: P. Speiser et al., CD44 IS AN INDEPENDENT PROGNOSTIC FACTOR IN EARLY-STAGE CERVICAL-CANCER, International journal of cancer, 74(2), 1997, pp. 185-188
Authors:
KRAMERGUTH A
QUASCHNING T
GALLE J
BAUMSTARK MW
KONIGER M
NAUCK M
SCHOLLMEYER P
MARZ W
WANNER C
Citation: A. Kramerguth et al., STRUCTURAL AND COMPOSITIONAL MODIFICATIONS OF DIABETIC LOW-DENSITY LIPOPROTEINS INFLUENCE THEIR RECEPTOR-MEDIATED UPTAKE BY HEPATOCYTES, European journal of clinical investigation, 27(6), 1997, pp. 460-468
Authors:
OLBRICHT C
WANNER C
EISENHAUER T
KLIEM V
DOLL R
BODDAERT M
OGRADY P
KREKLER M
MANGOLD B
CHRISTIANS U
Citation: C. Olbricht et al., ACCUMULATION OF LOVASTATIN, BUT NOT PRAVASTATIN, IN THE BLOOD OF CYCLOSPORINE-TREATED KIDNEY GRAFT PATIENTS AFTER MULTIPLE DOSES, Clinical pharmacology and therapeutics, 62(3), 1997, pp. 311-321
Authors:
GALLE J
WANNER C
Citation: J. Galle et C. Wanner, IMPACT OF NITRIC-OXIDE ON RENAL HEMODYNAMICS AND GLOMERULAR FUNCTION - MODULATION BY ATHEROGENIC LIPOPROTEINS, Kidney & blood pressure research, 19(1), 1996, pp. 2-15
Authors:
WANNER C
Citation: C. Wanner, CLINICAL-SIGNIFICANCE OF LIPOPROTEIN(A) DETERMINATION IN PATIENTS WITH RENAL-DISEASE, JN. Journal of nephrology, 9(4), 1996, pp. 157-159
Authors:
SCHRAMM L
HEIDBREDER E
ZIMMERMANN J
LOPAU K
WANNER C
Citation: L. Schramm et al., ACUTE-RENAL-FAILURE - INFLUENCE OF NITRIC-OXIDE ON RENAL-FUNCTION, JN. Journal of nephrology, 9(3), 1996, pp. 118-125
Authors:
SCHWEDLER S
ROHRBACH R
WANNER C
Citation: S. Schwedler et al., NONRECURRENT PREGNANCY-ASSOCIATED THROMBOTIC MICROANGIOPATHY, JN. Journal of nephrology, 9(3), 1996, pp. 136-138
Authors:
BOMMER J
WERLE E
SACK IW
BOMMER C
WIELAND H
WANNER C
Citation: J. Bommer et al., D-THYROXINE REDUCES LP(A) IN DIALYSIS PATIENTS, Journal of the American Society of Nephrology, 7(9), 1996, pp. 962-962
Authors:
GALLE J
SCHWEDLER S
HEINLOTH A
WANNER C
Citation: J. Galle et al., ATHEROGENIC LIPOPROTEINS STIMULATE FORMATION OF SUPEROXIDE ANION AND RENIN SECRETION IN JUXTAGLOMERULAR CELLS - PREVENTION BY HIGH-DENSITY-LIPOPROTEIN, Journal of the American Society of Nephrology, 7(9), 1996, pp. 1414-1414
Authors:
GALLE J
SCHNEIDER R
WINNER B
WANNER C
Citation: J. Galle et al., GLYCOSYLATION AND OXIDATION INCREASES THE ENDOTHELIUM-DAMAGING EFFECTOF LDL - MEDIATED BY INCREASED FORMATION OF O2-, Journal of the American Society of Nephrology, 7(9), 1996, pp. 1559-1559
Authors:
KRAMERGUTH A
GALLE J
ANDRE M
ALBRECHT S
SCHOLLMEYER P
WANNER C
Citation: A. Kramerguth et al., RECEPTOR-MEDIATED UPTAKE OF NATIVE AND MODIFIED LOW-DENSITY LIPOPROTEINS (LDL) BY HUMAN MESOTHELIAL CELLS AND PERITONEAL-MACROPHAGES, Journal of the American Society of Nephrology, 7(9), 1996, pp. 2165-2165
Authors:
GREIBER S
DAXER C
SCHOLLMEYER P
WANNER C
Citation: S. Greiber et al., INFLUENCE OF LIPOPROTEIN (A) [LP(A)] ON FIBRONECTIN PRODUCTION IN CULTURED HUMAN MESANGIAL CELLS [MC], Journal of the American Society of Nephrology, 7(9), 1996, pp. 3037-3037
Authors:
GREIBER S
KRAMERGUTH A
PAVENSTADT H
GUTENKUNST M
SCHOLLMEYER P
WANNER C
Citation: S. Greiber et al., EFFECTS OF LIPOPROTEIN(A) ON MESANGIAL CELL-PROLIFERATION AND VIABILITY, Nephrology, dialysis, transplantation, 11(5), 1996, pp. 778-785
Authors:
WANNER C
Citation: C. Wanner, HMG-COA REDUCTASE INHIBITOR TREATMENT IN RENAL-INSUFFICIENCY, Nephrology, dialysis, transplantation, 11(10), 1996, pp. 1951-1952